Lars Køber

Showing 1-8 of 8 articles

Coronary interventions

Myocardial Damage After ST-Segment Elevation Myocardial Infarction According to the Use of Bivalirudin or Heparin A Cardiac Magnetic Resonance Substudy of the DANAMI3 trial

Schoos MM, Nepper-Christensen L, Ahtarovski KA, Kyhl K, Goransson C, Holmvang L, Kelbæk H, Helqvist S, Høfsten D, Køber L, Vejlstrup N, Lønborg J, Engstrøm T

December 17, 2019 | 10.4244/EIJ-D-19-00623

Coronary interventions

Fractional Flow Reserve Guided PCI in Patients With and Without Left Ventricular Hypertrophy: a DANAMI-3-PRIMULTI Sub-study

Sabbah M, Nepper-Christensen L, Lønborg J, Helqvist S, Køber L, Høfsten D, Ahtarovski K, Goransson C, Kyhl K, Schoos M, Vejlstrup N, Kelbæk H, Engstrøm T

November 20, 2019 | 10.4244/EIJ-D-19-00577

Characterisation of lesions undergoing ischaemia-driven revascularisation after complete revascularisation versus culprit lesion only in patients with STEMI and multivessel disease: a DANAMI-3-PRIMULTI substudy

De Backer O, Lønborg J, Helqvist S, Warnøe J, Kløvgaard L, Holmvang L, Pedersen F, Tilsted H, Raungaard B, Jørgensen E, Køber L, Høfsten D, Kelbæk H, Engstrøm T

June 20, 2019 | 10.4244/EIJ-D-18-00766

STEMI

Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI: a DANAMI-3 substudy

Nepper-Christensen L, Lønborg J, Hofsten D, Ahtarovski K, Kyhl K, Goransson C, Køber L, Helqvist S, Pedersen F, Kelbæk H, Vejlstrup N, Holmvang L, Engstrøm T

August 24, 2018 | 10.4244/EIJ-D-17-00857

Coronary interventions

Bleeding episodes in “complete, staged” versus “culprit only” revascularisation in patients with multivessel disease and ST-segment elevation myocardial infarction: a DANAMI-3-PRIMULTI substudy

Sadjadieh G, Engstrøm T, Helqvist S, Hofsten D, Køber L, Pedersen F, Clemmensen P, Jørgensen E, Saunamäki K, Tilsted H, Kelbæk H, Holmvang L

November 20, 2016 | 10.4244/EIJV12I10A203

Coronary interventions

Acute myocardial infarction and lesion location in the left circumflex artery: importance of coronary artery dominance

Waziri H, Jørgensen E, Kelbæk H, Fosbøl E, Pedersen F, Mogensen U, Gerds T, Køber L, Wachtell K

July 20, 2016 | 10.4244/EIJY15M09_04

Coronary interventions

A post hoc analysis of long-term prognosis after exenatide treatment in patients with ST-segment elevation myocardial infarction

Kyhl K, Lønborg J, Vejlstrup N, Kelbæk H, Helqvist S, Holmvang L, Jørgensen E, Saunamäki K, Bøtker H, Clemmensen P, Køber L, Treiman M, Engstrøm T

July 20, 2016 | 10.4244/EIJV12I4A78

Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study

Kelbæk H, Engstrøm T, Ahtarovski K, Lønborg J, Vejlstrup N, Pedersen F, Holmvang L, Helqvist S, Saunamäki K, Jørgensen E, Clemmensen P, Kløvgaard L, Tilsted H, Raungaard B, Ravkilde J, Aaroe J, Eggert S, Køber L

February 22, 2013 | 10.4244/EIJV8I10A175

Latest news

New issue

EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more

(3D volume-rendered CCTA LAA example)

January 17, 2020

Editorial

From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology”

Robert Byrne

January 17, 2020

JAA

New this week: Inferior caval valve implantation for severe tricuspid regurgitation

January 14, 2020

TRIALS BOOK

Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ...

(The Trials book is supported by Biotronik)

January 15, 2020

Guidance Papers

Guidelines, consensus & position papers

April 9, 2019

Editorial

The role of the Heart Team in the planning of aortic valve replacement

January 15, 2020

JAA

Last week's JAA's: Paravalvular leak after TAVI & TAVI with ACURATE NEO

January 7, 2020

Lars Køber

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke